Stevanato Group

Stevanato Group Since 1949, one of the largest biopharma providers of integrated containment and delivery solutions.

14/01/2025

📅 Join us in Paris for Pharmapack 2025!

On the 22nd and 23rd of January, we will be glad to showcase our innovations in drug containment solutions, drug delivery devices, and contract manufacturing capabilities!

Don't miss our speech about “A new dimension for a better injection experience”, by our colleague Enrico Barichello on January 22nd, from 12:10 pm to 12:40 pm CET at the Learning Lab Theatre K3.

And you must also come to see our EZ-fill Smart™ ready-to-use vial platform for aseptic manufacturing at the Product Gallery, F12.

Book a meeting with us – you will find us at booth F41: https://www.stevanatogroup.com/en/meetings/pharmapack-paris-2025/

🌟 Enhancing Biologics Production with Ready-to-Use (RTU) vials 🌟At Stevanato Group, our EZ-fill® RTU vials are designed ...
09/01/2025

🌟 Enhancing Biologics Production with Ready-to-Use (RTU) vials 🌟

At Stevanato Group, our EZ-fill® RTU vials are designed to meet the stringent requirements of biologics production, delivering safety, efficiency, and quality.

🔬 Why Choose Our RTU Solutions?

• Sterility Assurance: Pre-washed and pre-sterilized to minimize contamination risks.
• Efficiency: Streamline production processes and reduce downtime.
• Quality: Protect the sensitive nature of biologics, maintaining stability and efficacy.

Join us in enhancing biologics production with our state-of-the-art EZ-fill® RTU vials. Together, we can make a difference in patient care.

🔍 Discover all their features here: https://www.stevanatogroup.com/en/products-capabilities/drug-containment-solutions/vial-systems/

Mark these dates on your calendar for our upcoming events this January and February!👉 From 22nd to 23rd January, you wil...
07/01/2025

Mark these dates on your calendar for our upcoming events this January and February!

👉 From 22nd to 23rd January, you will find us at the Paris Expo, Porte de Versailles - Hall 7.2 for Pharmapack Paris 2025. Come to our booth F41 to explore our latest innovations in drug containment solutions, drug delivery devices, and contract manufacturing capabilities.

👉 From 4th to 6th February, we will be at the Anaheim Convention Center, USA, at MD&M West. Meet us at booth #2822 to learn more about our precision injection molding and assembly capabilities for diagnostic and drug delivery solutions.

Find all the details here and don’t forget to book a meeting with our experts: https://www.stevanatogroup.com/en/news-events/events/

18/12/2024

🌍 The customer is the energy that moves our world!

As we look back on a year full of challenges, successes, and meaningful connections we want to thank our clients and partners for their valuable support.

With Christmas just around the corner, it’s now time to enjoy precious moments with our loved ones. Let’s rest and recharge, to be ready to embark on an even more exciting journey together in 2025!

✨From all of us at Stevanato Group, a joyful holiday season and a wonderful New Year.

16/12/2024

Discover our semi-automatic benchtop unit, designed to support you from the early stage of your development or assembly process.
This unit is part of our platform, which allows for a smooth technology transfer and production ramp-up, from benchtop to a fully automatic machine for your commercial production.

Our benchtop stands out for its flexibility since it allows you to process many different types of auto-injectors available on the market. One of the devices compatible with this versatile benchtop unit is Aidaptus®, a two-step, single-use auto-injector, which accommodates both 1mL and 2.25 mL pre-filled glass syringes in the same form factor.

Watch the video for an in-depth look 👇 https://www.stevanatogroup.com/en/technologies-equipment/assembly-equipment/assembly-platforms/

✨ We are honored to have received, for the second consecutive year, the Certificate of Resilience from Biocon Biologics ...
12/12/2024

✨ We are honored to have received, for the second consecutive year, the Certificate of Resilience from Biocon Biologics during their Symposia 2024 – Annual Supplier Conference, which recognizes our resilience in ensuring supply continuity, even under adverse conditions.

The event brought together Biocon's leading industry professionals, key suppliers and thought leaders where we were pleased to participate in the panel discussion on “Circular Economy & Biopharma SCM,” emphasizing our commitment to ESG and Circular Economy initiatives while presenting our innovative solutions in this area.

11/12/2024

▶️ Our webinar ‘Tailoring GLP-1 Biosimilar Delivery Systems for the Expanding Obesity Market’ is now available on-demand!

Don't miss the opportunity to gain valuable insights from our experts Tommaso Borghi, Manuela Giacon, and Sara Silvagni as they explore innovative solutions that meet the design and industrial challenges of GLP-1 biosimilar delivery systems.

You can follow the webinar on-demand here: https://www.stevanatogroup.com/en/news-events/webinars/tailoring-glp-1-biosimilar-delivery-systems-for-the-growing-obesity-market/

❄️ The mechanical and Container Closure Integrity (CCI) performance of our 2R Fina® glass vials have been successfully t...
10/12/2024

❄️ The mechanical and Container Closure Integrity (CCI) performance of our 2R Fina® glass vials have been successfully tested under various conditions, proving their suitability at very low temperatures over a storage period of 24 months.

In our article, we present a comprehensive study demonstrating their suitability for storing sensitive molecules under deep cold conditions. Interested to know more? Read the full article here: https://www.stevanatogroup.com/en/news-events/news/2r-vials-and-deep-cold-storage-determining-mechanical-cci-performances/

09/12/2024

🌟 Are you looking for a reliable, high-speed unit for inspecting your challenging high-value drugs?

Discover our CVT Core Inspection machine for syringes, designed to process your valuable drugs at high speed.

Key features include:

✅ Denesting, inspection, and renesting all in a single machine with a compact footprint;
✅ Recipe-controlled spinning schedule for even more precise and accurate inspection;
✅ Flexibility and speed combined to support your production.

Learn more about how our CVT Core unit is the ultimate choice to meet the challenges in high-value drug inspection: https://www.stevanatogroup.com/en/technologies-equipment/visual-inspection/automatic-inspection-equipment/cvt-core/

🔎Not sure if your primary container has adequate Container Closure Integrity (CCI)? Stevanato Group’s US Technology Exce...
05/12/2024

🔎Not sure if your primary container has adequate Container Closure Integrity (CCI)?

Stevanato Group’s US Technology Excellence Center can help you navigate the multitude of tests in USP to determine your drug container’s inherent package integrity, down to the maximum allowable leak limit (MALL) for microbial ingress.

Demonstrate the CCI of your finished primary container by using our state-of-the-art deterministic Helium-leak method to keep your drug safe and effective today!

👉 Discover more: https://www.stevanatogroup.com/en/analytical-testing-services/analytical-services/container-performance/

Looking for the right partner for your vaccine manufacturing needs?The vaccine landscape is evolving rapidly, driven by ...
04/12/2024

Looking for the right partner for your vaccine manufacturing needs?

The vaccine landscape is evolving rapidly, driven by innovative technologies such as mRNA, recombinant, viral vector, and combination vaccines.

Stevanato Group can serve vaccine production processes with comprehensive solutions covering the full pharma value chain. Our unique position in the market enables us to be an integrated provider of analytical services, primary packaging, inspection and packaging equipment.

⏩ Discover our solutions, ideal for high-speed, high-volume production: https://www.stevanatogroup.com/en/markets/vaccines/

02/12/2024

📅 Only two days left until our webinar, “Tailoring GLP-1 Biosimilar Delivery Systems for the Expanding Obesity Market”.

Join this insightful session with our experts Tommaso Borghi, Manuela Giacon and Sara Silvagni as we delve into how our solutions can support the design and industrialization of GLP-1 biosimilar delivery systems.

Don’t miss it out! You can register until tomorrow at 2:00 PM (CET): d5ec7ba9-95af-4b87-9ba1-9640866e3399@c7cf94a7-9ec7-47b8-abe7-19a7bbea4291" rel="ugc" target="_blank">https://events.teams.microsoft.com/event/d5ec7ba9-95af-4b87-9ba1-9640866e3399@c7cf94a7-9ec7-47b8-abe7-19a7bbea4291

🌟 Siamo lieti di partecipare al congresso “Intreccio di saperi tra Accademia e Industria: il caso dei complex drugs” dov...
27/11/2024

🌟 Siamo lieti di partecipare al congresso “Intreccio di saperi tra Accademia e Industria: il caso dei complex drugs” dove la nostra collega Odra Pinato farà uno speech durante la Sessione IV di domani, con l’intervento “The role of primary packaging in complex drug stability”.

L’incontro riunisce figure di rilievo del mondo accademico ed industriale che, insieme, hanno esplorato le nuove frontiere delle “complex drugs” per la somministrazione parenterale. Questi medicinali sono considerati complessi dal punto di vista tecnologico e regolatorio - per via della composizione del farmaco e dei processi produttivi correlati - e richiedono un’azione sinergica di competenze chimiche, biologiche e ingegneristiche.

Università degli Studi di Milano

The increasing use of RNA-based drugs, either through vials or pre-filled syringes, comes with some manufacturing challe...
21/11/2024

The increasing use of RNA-based drugs, either through vials or pre-filled syringes, comes with some manufacturing challenges. The RNA molecule, in fact, is typically encapsulated in lipid nanoparticles that exhibit high sensitivity to particulates in the container closure system.

To address these needs, we support RNA-based drug manufacturing with dedicated solutions in primary packaging, machinery, and analytical services that can be integrated across the entire pharmaceutical value chain.

⏩ Discover how Stevanato Group can be your single interface providing a science-based approach to help you advance your RNA-based drug programs efficiently and reliably: https://www.stevanatogroup.com/en/markets/rna-based-drugs/

20/11/2024

Discover our highly efficient labeling and top-loaded packaging line, allowing for fast, automatic batch changeover. With a downstream connection to the case packer and palletizer, cartoning, and high-speed labeling with auto-splice for continuous production, this line can meet even the most stringent customer requirements.

Among its key features:

✅ Digital Twin and data collection platform available for optimized management
✅ Vacuum-based fixtures offering maximum flexibility for multiple formats
✅ Fully automated material handling

Learn more about this complete solution in our new video 👇 https://www.stevanatogroup.com/en/technologies-equipment/flexible-packaging-machines/labeling-packaging-serialization/

✨ Live from our Headquarters in Piombino Dese! We are honored to be hosting a two-day PDA training on “Test Methods for ...
18/11/2024

✨ Live from our Headquarters in Piombino Dese! We are honored to be hosting a two-day PDA training on “Test Methods for Pre-Filled Syringe Systems”! ✨

A unique opportunity to engage with PDA experts in an interactive lecture on pre-filled syringe systems, ISO compliance testing, and the PFS lifecycle.

During the course, we are sharing valuable, experience-based insights, while exploring our Technology Excellence Centers – with an exclusive tour of our Pre-Filled Syringe production process.

What a fantastic day! Take a snapshot of today’s key highlights! 👇

Parenteral Drug Association - PDA

Indirizzo

Via Molinella 17
Piombino Dese
35017

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Stevanato Group pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.

Video

Condividi

Mission

We are committed to create systems, processes and services that guarantee the integrity of injectable drugs giving our key contribution to the overall improvement of the pharmaceutical industry.

And we never stand still: Our continual innovation leads us to produce the world’s most advanced solutions year after year.

____________________________________________________________ Siamo impegnati a creare sistemi, processi e servizi in grado di garantire l'integrità dei farmaci iniettabili dando il nostro contributo al progresso dell'industria farmaceutica.

E non ci fermiamo mai: la nostra continua sete di innovazione ci spinge a produrre le più avanzate soluzioni al mondo, anno dopo anno.